HELSINKI, 12-11-2015 — /EuropaWire/ — Sampo’s Group CEO and President Kari Stadigh has today sold 54,390 Sampo A shares. After the transaction he holds 251,795 Sampo A shares. The sold shares had been owned by Kari Stadigh for more than … Read the full press release
Posted in Business, Financial, Finland, Insurance, Investment, Management
Tagged Kari Stadigh, Sampo A shares, Sampo's Group
Helsinki, Finland, 14-2-2014 — /EuropaWire/ — Sampo Group’s profit before taxes for 2013 rose to EUR 1,668 million compared to EUR 1,622 million in 2012. Total comprehensive income for the period, taking changes in the market value of assets into account, amounted … Read the full press release
Posted in Business, Financial, Finland, Insurance, Investment, Management
Tagged increased dividend, Kari Stadigh, Maria Silander, profit before taxes, Sampo Group, Sampo's dividend
16-8-2013 — /EuropaWire/ — Sampo Group’s profit before taxes for the first half of 2013 amounted to EUR 825 million compared to EUR 813 million a year earlier. The total comprehensive income for the period, taking changes in the market value … Read the full press release
23-5-2013 — /europawire.eu/ — Good development continued as Sampo Group’s profit before taxes for the first quarter of 2013 amounted to EUR 370 million compared to EUR 370 million in the first quarter of 2012. Earnings per share remained at EUR … Read the full press release
Posted in Business, Financial, Finland, Insurance, Investment
Tagged earnings, Kari Stadigh, Net asset, profit, profit before taxes, Q1 2013 Results, Sampo, Sampo Group
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
